Blood Tumor Mutational Burden as a Predictive Biomarker in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Pakistan Journal of Medical & Cardiological Review, [S. l.], v. 5, n. 2, p. 2361–2369, 2026. DOI: 10.66021/pakmcr1041. Disponível em: https://pakjmcr.com/index.php/1/article/view/1041. Acesso em: 19 nov. 2026.